Intezyne is a clinical-stage biotechnology company focused on increasing the effectiveness of cancer treatments through the application of a diverse portfolio of proprietary assets. The Company is currently advancing these assets through various stages of the clinical approval process.
Looking for a particular Intezyne Technologies employee's phone or email?
The Intezyne Technologies annual revenue was $6.5 million in 2026.
Daniel Devers is the CBO of Intezyne Technologies.
2 people are employed at Intezyne Technologies.
Intezyne Technologies is based in Tampa, Florida.
The NAICS codes for Intezyne Technologies are [325, 3254, 32541, 32].
The SIC codes for Intezyne Technologies are [283, 28].